INS and Hyperglycemia: In diabetes, activation of the pancreatic RAS by hyperglycaemia and hyperlipidaemia can result in reduced insulin biosynthesis, insulin secretion, and islet blood flow, and also increased β-cell apoptosis, oxidative stress, and islet fibrosis [14, 19].